ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "morbidity and mortality and rheumatoid arthritis (RA)"

  • Abstract Number: 2652 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis and Excess Mortality Associated with Treatments: a Systematic Review and Meta-Analysis

    Manon Redondin1, B Combe2, Cécile Gaujoux-Viala3, Jacques Morel4 and Cédric Lukas5, 1CHU Lapeyronie, University of Montpellier, France, 2Immuno-Rhumatologie, CHU Lapeyronie, University of Montpellier, France, 3CHU Nîmes, University of Montpellier, France, 4Rheumatology, Department of Rheumatology, Montpellier University Hospital, Montpellier, France, 5Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France

                                                                                                                                                                            Background/Purpose: Patients with rheumatoid arthritis (RA) have a lower life expectancy than general population. The impact of RA treatments on global mortality is not…
  • Abstract Number: 3052 • 2016 ACR/ARHP Annual Meeting

    Causes of Death for Patients with Rheumatoid Arthritis

    Jessica Widdifield1, Michael Paterson2, Anjie Huang3, Bindee Kuriya4, Carter Thorne5, Janet E. Pope6, Claire Bombardier7 and Sasha Bernatsky8, 1McGill University, Toronto, ON, Canada, 2Institute of Clinical Evaluative Sciences, Toronto, ON, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 4Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 5University of Toronto and Southlake Regional Health Centre, Newmarket, ON, Canada, 6University of Western Ontario, St Joseph's Health Care, London, ON, Canada, 7University of Toronto, Toronto, ON, Canada, 8Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Information on causes of death can assist in monitoring health trends and discovering health gaps. Our aim was to determine the primary causes of…
  • Abstract Number: 1343 • 2015 ACR/ARHP Annual Meeting

    Mortality Due to Sepsis in Patients with Rheumatoid Arthritis

    Orit Barrett1, Ella Abramovich2, Jacob Dreiher3, Victor Novack4 and Mahmoud Abu-Shakra5, 1Department of Medicine D, Soroka Medical Center and Ben-Gurion University, Beersheba, Israel, 2Department of Medicine D, Soroka University Medical Center and Ben-Gurion University, Beersheba, Israel, 3Clalit Health Services, Ben-Gurion University of the Negev, Beer Sheva,,, BeerSheba, Israel, 4Clinical Research Center, Soroka Medical Center and Ben-Gurion University, Beersheba, Israel, 5Rheumatic Diseases Unit, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

    Background/Purpose: Severe infections contribute significantly to the morbidity and mortality of patients with rheumatoid arthritis. The aim of the study was to  identify the characteristics…
  • Abstract Number: 1534 • 2015 ACR/ARHP Annual Meeting

    Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations

    Narender Annapureddy1, Achint Patel2, Rabi Yacoub3, Krishna Pakanati4, Shiv Agarwal5, Priya Simoes6, Shaan Patel3, Sunil Kamat7, Alexandre Benjo8 and Girish Nadkarni9, 1Rheumatology and Immunology, Vanderbilt University, Nashville, TN, 2Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 3Icahn School of Medicine at Mount Sinai, New York, NY, 4Gateway Medical Center, Clarksville, TN, 5Cardiology, University of Arkansas Medical Sciences, Little Rock, AR, 6Internal Medicine, St.Lukes Roosevelt Hospital Center at Mount Sinai, New York, NY, 7Critical Care, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India, 8Ochsner Clinic Foundation, New Orleans, NY, 9Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased risk of cardiac mortality. With better treatment modalities, some studies suggest that infarction (AMI) mortality in RA…
  • Abstract Number: 1562 • 2015 ACR/ARHP Annual Meeting

    Clinical Correlates, Outcomes and Predictors of Episcleritis and Scleritis Associated with Rheumatoid Arthritis

    Cristian Caimmi1, Wendy M. Smith2, Cynthia S. Crowson3, Eric L. Matteson4 and Ashima Makol5, 1Unit of Rheumatology, Department of Medicine,, University of Verona, Verona, Italy, 2Department of Ophthalmology, Mayo Clinic, Rochester, MN, 3Division of Rheumatology and Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

    Background/Purpose: Inflammatory ocular disease (IOD) has traditionally been regarded as a severe extra-articular manifestation of rheumatoid arthritis (RA) with high mortality. This study aims to…
  • Abstract Number: 1999 • 2015 ACR/ARHP Annual Meeting

    Improvement in Mortality in RA Compared to the General Population – Closing the Mortality Gap

    Diane Lacaille1,2, Eric C. Sayre3 and Michal Abrahamowicz4, 1Rheumatology, University of British Columbia, Vancouver, BC, Canada, 2Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, 3Arthritis Research Canada, Richmond, BC, Canada, 4Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada

    Background/Purpose: Increased mortality in RA is believed to be a consequence of inflammation. With improved treatment, mortality would be expected to decrease over time. The…
  • Abstract Number: 3237 • 2015 ACR/ARHP Annual Meeting

    Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?

    Elena Myasoedova1, Cynthia S. Crowson2, Eric L. Matteson3, John M. Davis III4, Terry M. Therneau5 and Sherine E. Gabriel6, 1Internal Medicine and Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Mayo Clinic, Rochester, MN, 5Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 6Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased cardiovascular (CV) morbidity and mortality as compared to the general population. Recent prospective studies with limited follow-up…
  • Abstract Number: 3239 • 2015 ACR/ARHP Annual Meeting

    Response to Methotrexate Predicts Mortality in Rheumatoid Arthritis up to 30 Years

    Carolin Krause1, Siegfried Wassenberg2, Rolf Rau3, Gertraud Herborn4, Juergen Braun5 and Dietmar Krause6, 1University Munster, Munster, Germany, 2Rheumaklinik, Themistocles Gluck hospital - Rheumazentrum Ratingen, Ratingen, Germany, 3Expert in Rheumatology, Düsseldorf, Germany, 4Evangelisches Fachkrankenhaus Ratingen, Ratingen, Greece, 5Rheumazentrum Ruhrgebiet, Herne, Germany, 6Dept. for Medical Informatics, Biometry and Epidemiology, Ruhr University, Bochum, Germany

    Background/Purpose: Methotrexate (MTX) is considered as the anchor drug for the treatment of patients with rheumatoid arthritis (RA). MTX has been shown to reduce disease…
  • Abstract Number: 40 • 2015 ACR/ARHP Annual Meeting

    Increased Mortality in Indigenous North Americans Persons with Rheumatoid Arthritis Is Partially Explained By Psychiatric and Physical Comorbidity: a Population Based Study

    Carol Hitchon1, Sazzadul Khan2, Brenda Elias3, Alan Katz4 and Christine A. Peschken5, 1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 2Manitoba Centre for Health Policy and Research, University of Manitoba, Winnipeg, MB, Canada, 3Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 4Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, MB, Canada, 5Arthritis Center, University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with excess mortality.  Indigenous North Americans (INA) in our region have high RA prevalence rates and young age at onset yet experience…
  • Abstract Number: 580 • 2015 ACR/ARHP Annual Meeting

    Treatment with Biologic Agents in Rheumatoid Arthritis and Mortality Risk in Clinical Practice

    Leticia Leon1, Luis Rodriguez-Rodriguez1, Alejandro Gomez-Gomez2, Pilar Macarrón2, Margarita Blanco2, Juan A Jover2 and Lydia Abasolo1, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose: It is a well-known fact the decline of life expectancy in Rheumatoid Arthritis (RA) being the increased mortality in these patients a constant concern…
  • Abstract Number: 2810 • 2014 ACR/ARHP Annual Meeting

    Reduced Mortality Risk in Rheumatoid Arthritis: Findings from Two UK Inception Cohorts

    Sam Norton1, Elena Nikiphorou2, Lewis Carpenter3, David Walsh4,5, Patrick Kiely6, Josh Dixey7 and Adam Young2,8, 1Institute of Psychiatry, King's College London, London, United Kingdom, 2School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3Centre for Lifespan & Chronic Illness Research, University of Hertfordshire, Hatfield, United Kingdom, 4Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, United Kingdom, 5Rheumatology, Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, United Kingdom, 6Rheumatology Dept, St. Georges Healthcare NHS Trust, London, United Kingdom, 7Rheumatology, New Cross Hospital, Wolverhampton, United Kingdom, 8Rheumatology, ERAS, St Albans City Hospital, St Albans, United Kingdom

    Background/Purpose Rheumatoid arthritis (RA) is associated with a 20 to 30% increased risk of mortality from all-causes compared to the general population. The aim of…
  • Abstract Number: 2388 • 2014 ACR/ARHP Annual Meeting

    DMARD Use after an Initial Acute MI Is Associated with Reduced Risk of a Recurrent Event and Mortality

    Jie Zhang1, Fenglong Xie2, Lang Chen3, Huifeng Yun4, Paul M. Muntner5, Emily Levitan5, Monica Safford6, Kenneth G. Saag7, Jasvinder A. Singh6 and Jeffrey R. Curtis6, 1Ryals Soph Bldg., Rm. 517b, Univ. of Alabama at Birmingham, Birmingham, AL, 2Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 3Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, 5Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 6University of Alabama at Birmingham, Birmingham, AL, 7Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose Previous studies have suggested that disease modifying anti-rheumatic drugs (DMARDs) may reduce cardiovascular risk among patients with rheumatoid arthritis (RA). This analysis examined whether…
  • Abstract Number: 2116 • 2014 ACR/ARHP Annual Meeting

    Hospitalization Rates and Utilization Among Rheumatoid Arthritis Patients: A Population-Based Study from 1987 to 2012

    C. John Michet III1, Katrina Strobova2, Sara J. Achenbach3, Cynthia S. Crowson4 and Eric L. Matteson5, 1Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, 2Department of Medicine, Charles University, Prague, Czech Republic, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose Patients with rheumatoid arthritis (RA) experience chronic management issues and are at risk for complex comorbidities. It is unknown, however, to what extent the…
  • Abstract Number: 2053 • 2014 ACR/ARHP Annual Meeting

    Mortality Decreases in Patients with Rheumatoid Arthritis: a 15-Year Prospective Cohort Study

    Joëlle van den Hoek1,2, Hendriek C. Boshuizen3, Leo D. Roorda4, Gerard J. Tijhuis5, Mike T. Nurmohamed5, Trudi van den Bos2 and Joost Dekker6,7, 1Rehabilitation Research Center, Reade, Rehabilitation | Rheumatology, Amsterdam, Netherlands, 2Social Medicine, Academic Medical Center, Amsterdam, Netherlands, 3National Institute of Public Health and the Environment, Bilthoven, Netherlands, 4Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 6Rehabilitation Medicine, Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 7Reade, centre for Rehabilitation and Rheumatology, Amsterdam, Netherlands

    Background/Purpose Patients with rheumatoid arthritis (RA) have a higher mortality risk than the general population, with similar patterns over the last decades. However, more recent…
  • Abstract Number: 1416 • 2014 ACR/ARHP Annual Meeting

    Analysis of Cardiac Involvement in Patients with Amyloid a (AA) Amyloidosis Due to Rheumatoidarthritis

    Daisuke Kobayashi1, Satoshi Ito1, Satoru Kodama1, Akira Murasawa1, Ichiei Narita2 and Kiyoshi Nakazono1, 1Niigata Rheumatic Center, Shibata, Japan, 2Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

    Background/Purpose Rheumatoid arthritis (RA) is one of the major causes of amyloid A (AA) amyloidosis. The major organs affected are the kidneys and gastrointestinal (GI)…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology